More effective cell therapies for more cancer patients
Critically ill patients are now struggling to access cell therapies like CAR-T, and when they do, they don’t work as well as they could
We’re empowering patients with a new option to bank their immune cells for future cell therapy
How do we do it?
Our growing network of oncologists allows us to reach cancer patients very early in their treatment journey - often at diagnosis - and offer them the option to store their immune cells at no cost to them.
We collect and store the cells in a way that should be acceptable for future cell therapy manufacturing. Patients can participate knowing that they are taking an action proactively that meaningfully improves their outlook.
Benefits for all
Patients get an early, free option that streamlines access to a cell therapy trial.
Doctors no longer have to watch a patient’s chances to get a cell therapy evaporate as the cancer progresses and standard of care fails them.
Cell therapy innovators have new, unprecedented access to patients and their cells to accelerate trial enrollment and boost outcomes.